SEC Form 4 · accession 0001053369-15-000021
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
EPIC PHARMA LLC
10% Owner
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Apr 27, 2015 | J | 67,659,232 | $0.00 | D | 0 | I | By Epic Investments, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person, Epic Pharma, LLC ("EP") owned 100% of the outstanding equity interests, was an equity owner of Epic Investments, LLC ("EI"). The interest of EP in the securities of the issuer owned by EI was limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
- F2Disposition of common stock to its members